locally advanced rectal cancer
Conditions
Interventions
Observation group:None
Sponsors
Southern Medical University Southern Hospital
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: 1.Voluntarily sign the informed consent form; 2.Age >= 18 years at enrollment; 3.Eastern Cooperative Oncology Group (ECOG) performance status 0–1; 4.Any sex; 5.Histologically confirmed rectal adenocarcinoma; 6.Diagnosed as stage II–III rectal cancer according to the American Joint Committee on Cancer (AJCC) 8th edition TNM staging system; 7.Has an indication for pelvic radiotherapy; 8.Adequate bone marrow function;
Exclusion criteria
Exclusion criteria: 1.Patients with bone marrow metastases detected by imaging examination; 2.Patients with metallic foreign bodies or artificial hip joint replacements; 3.History of other malignant tumors; 4.Presence of serious diseases (e.g., heart failure or psychiatric disorders); 5.Patients who are pregnant or breastfeeding; 6.Patients concurrently participating in other clinical trials; 7.Patients deemed unsuitable for participation in this study by the investigator;
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Dose-volume parameters; | — |
Countries
China
Contacts
Public ContactZhang Yaowei
Southern Medical University Southern Hospital
Outcome results
None listed